1. Alper MM, Jolly EE and Gamer PB:
Pregnancies after premature ovarian failure. Obstet. Gynecol. 1986; 67: 598.
2. Bauer DC, Browner WS, Cauley JA, et al. Factors associated to bone
mass in advanced age women limbs. Ann. Intern. Med. 1993; 118: 657-665.
3. Bear RJ. Genital organs in the menopause. En: van Keep PA et al.
"Consensus on Menopause Research". University Park Press, Baltimore, 1976.
4. Ben- David M and L Hermie M: Prolactin and menopause. En: van Keep
PA, et al. "Consensus on Menopause Research". University Park Press, Baltimore,
1976.
5. Benedek- Jaszman LJ. Long term placebo-controlled efficacy and
safety study of Org 14 in climacteric women. Maturitas 1987; supl. 1: 25-33.
6. Bergh T. The pathophysiological relation beween prolactin and bone
mass. En: Christiansen C. "New Horizons in Osteoporosis". The Parthenon
Publishing Group Ltd., Camforth, 1988.
7. Bergqvist A, Bergqvist D and Ferno M. Estrogen and progesterone
receptors in vascular wall; biochemical and inmmunochemical assays. Acta Obstet. Gynecol.
Scand. 1993; 72 (1): 10-16.
8. Brincat M. Skin and the menopause. En: Greenblatt RB "A Modem
Approach to the Perimenopausal Years". Walter de Gruyter, Berlin New York, 1986.
9. Burch JC, Byrd BF and Vaughn WK: Results of estrogen treatment in
one thousand hysterectornized women for 14318 years. En van Keep PA et al "Consensus
on Menopause Research". University Park Press, Baltimore, 1976.
10. Chetkowski RJ, Meldrum DR, Steingold KA, Randle, et al. Biologic
effects of transdermal estradiol. Obstet. Gynecol. Survey 1986; 41: 710.
11. Christiansen C. New Horizons in Osteoporosis. The Parthenon
Publishing Group Ltd., Camforth, 1988.
12. Collins P, Rosano GMC, Jiang C et al. Estrogen cardiovascular
protection; a calcium antagonist effect. Lancet 1993; 341, 1264-1265.
13. Committee on Diet, Nutrition and Cancer, Assembly of Life Science;
Diet, Nutrition and Cancer. National Academic Press, Washington DC, 1982.
14. Coulam CB, Adamson SC and Annegers JF. Incidence of premature
ovarian failure. Obstet. Gynecol. Survey 1987; 42: 182.
15. Coyotupa J, González S, Zorrilla R, González G y Guerra García
R. Menarquía y menopausia en la altura. Obstet. Ginec. (Perú) 1991; 37: 43.
16. Cummings SR and Black D. Should perimenopausal women be screened
for osteoporosis Obstet. Gynecol. Survey 1987; 42: 43.
17. Cummings SR: Benefits and risks of long- term postmenopusal hormone
therapy. En: Samsioe G "Cardiovascular Disease and HRT, New perspectives". The
Parthenon Publishing Group, Camforth, New Jersey, 1991.
18. Dequerer J. and Ferin J. Effect of long- term estrogen therapy on
bone remodelling in women with a natural menopause: cross sectional and longitudinal
study: en van Keep PA et al "Consensus on Menopause Research". University Park
Press, Baltimore, 1976.
19. Dupont WD and Page DL. Menopausal estrogen replacement therapy and
breast cancer (see comments) Comment in: Arch. Intern. Med. 1991; 151 (1): 17-8. Arch.
Intern. Med. 1991; 151: 67-72.
20. Flint M. Cross-cultural factors that affect age of menopause. En:
van Keep PA -Consensus on Menopause Research. University Park Press, Baltimore, 1976.
21. Gobert B, Barbarino- Monnier P, Guillet-May F, Bette MC and Faure
GC. Antiovary antibodies after attempts at human in vitro fertilization induced by
follicular puncture rather than hormonal stimulation. J. Reprod. Fertil. 1992; 96 (1):
213-8.
22. Godsland IF, Walton C and Stevenson JC: Carbohydrate metabolism as
a cardiovascular disease risk factor- Its relation to menopause and hormone replacement
therapy. En Sarnsioe G "Cardiovascular Disease and HRT. New perspectives". The
Parthemon Publishing Group, Camforth, New Jersey, 1991.
23 Gonzales GF, and Carrillo C. Serotonine blood levels in
postmenopausal women; effect of age an serum levels of estradiol. Maturitas 1993; 17,
23-29.
24. Gonzales - Merlo J. Ventajas e inconvenientes del tratamiento
hormonal sustitutivo en la menopausia., En: Palacios S. Climaterio y Menopausia. MIRPAL,
Madrid, 1993.
25. Greenblatt RB and Gambrell RD. Estrogens and endometrial cancer.
En: van Kepp PA, et al. "Consensus on Menopausal Research". University Park
Press, Baltimore, 1976.
26. Haarbo J, Hassager C, Jensen SB, Riis BJ, and Christiansen C. Serum
lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement
therapy combined with either 19- nortestosterone derivatives or 17-hyroxyprogesterone
derivatives. Am. J. Med. 1991; 90: 584-9.
27. Husmann F: Longterm metabolic effects of estrogen therapy. En:
Greenblatt RB. "A Modem Approach to the Perimenopausal Years". Walter de
Gruyter, Berlin-New York, 1986.
28. Instituto Nacional de Estadística e Informática: Perú, Encuesta
Demográfica y de Salud Familiar 1991/1992. INEI, 1992.
29. Jacobson PC, Beavez W, Arubb SA, et al. Bone density in women;
college athletes and older athletic women. J. Orthop. Res. 1984; 2: 328.
30. Judd HL. Menopause & postmenopause. En: Pernoll ML & Benson
RC. "Current Obstetric & Gynecologic Diagnosis & Treatment. Appleton &
Lange", Norwalk/Los Altos, 1987.
31. Kikovic PM, Cortes-Prieto J, Luisi M, Millojevic S, and Franchi F.
Placebo controlled cross-over study of effects of Org. OD 14 in menopausal women.
Reproduction 1982; 6; 81-91.
32. Kobayashi, Nakano R, and Shima K. Immuno- histochemical
localization of pituitary gonadotrophins and estrogens in human postmenopausal ovaries.
Acta Obstet. Gynecol. Scan. 1993; 72, 77-80.
33. Larsson- Cohn U, Wallentin L. Sex seroids and lipoproteins. En:
Greenblatt RB A Modern Approach to the Perimenopausal Years. Walter de Gruyter, Berlin-
New York, 1986.
34. Lauritzen Ch. The estrogen deficiency syndrome and the management
of the patient. En: van Keep PA, et al. "Consensus on Menopause Research".
University Park Press, Baltimore, 1976.
35. Lauritzen C. El Climaterio de la Mujer. Gráficas Carman, Colombia,
1983.
36. Lindgren R, Berg G, Hammmar M, et al. Hormonal replacement therapy
and sexuality in Swedish posmenopausal women. Acta Obstet. Gynecol. Scand. 1993; 72;
292-297.
37. Lecerf J. et al. Variations in lipoproteins lipid type fatty acid
composition in women of advanced age. Atheroesclerosis 1993; 98: 241-249.
38. Lindsay R. Osteoporosis: Ocurrence and diagnosis. En Greenblatt RB
"A Modern Approach to the Perimenopausal Years". Walter de Gruyter, Berlin - New
York. 1986.
39. MacLennan AH, MacLennan A., Wilson D, et al. Prevalence of estrogen
replacement therapy in South Australia. MATURITAS 1993; 16: 175-183.
40. Mauvais- Jarvis P, Kuterm F and Gompel A. Antiestrogen action of
progesterone in breast tissue. Breast Cancer Res. Treat. 1986; 8: 179.
41. Mishell DR, Connell E, Haney A, Hodgen G, and Speroff L. Oral
contraception for women in their 40s. J. Reprod. Med. 1990; 35; 447.
42. Neyhart B. Menopause. En: Havens C, Sullivan ND and Tilton
"Manual of Outpatient Gynecology", Little, Brown & Co., Boston/Toronto,
1986.
43. Nieer J, and Augustin W. Prostaglandin E and F profiles in human
fallopian tubes using different phases of the menstrual cycle. Gynecol. Obstet. Invest.
1986; 21: 202.
44. Nocke W. Some aspects of oogenesis, follicular growth, and
endocrine involution. En: Greenblatt RB "A Modern Approach to the Perimenopausal
Years". Walter de Gruyter, Berlin- New York 1986.
45. Odell WD and L'Hermite M. Releasing factors in the menopause. En
van Keep PA et al. "Consensus on Menopause Research". University Park Press,
Baltimore, 1976.
46. Oldenhave A, Jaszman LJB, Haspels AA, et al. Impact of menopause on
well being: a survey based on 5213 women aged 39 to 60 years old. Am. J. Obstet. Ginecol.
1993; 168, 722-780.
47. Oldenhave A, Jaszman LJB, et al. Hysterectomized women with ovaries
conservation refer more severe menopausal symptoms than normal menopausal women of similar
age. Am. J. Obstet. Gynecol. 1993; 168: 765-771.
48. Osmers R, Völksen M and Khun W. Postmenopausal endometrium
evaluation by vaginal ultrasound examination. Gynecol. Obstet. 1992; 87 (6): 309-315.
49. Pacheco JC, and Kempers RD. Etiology of postmenstrual bleeding.
Obstet. Gynecol. 1968; 32: 40.
50. Pacheco J. Contribución al estudio de la menopausia, climaterio y
patología ginecológica en la mujer peruana. Acta Médica Peruana 1984; 11: 29.
51. Pacheco J. Manejo actual del climaterio y la menopausia. Medicina
al Día 1993; 2: 25-31.
52. Palacios N. Alimentación y nutrición en la mujer
postmenopáusica. En Palacios S: Climaterio y Menopausia. Mirpal, Madrid, 1993.
53. Palacios S. Climaterio y Menopausia. Mirpal, Madrid, 1993.
54. Palacios S. Comunicación personal.
55. Penzias AS, Thompson IE, Alper MM, Oskowitz SP and Berger MJ.
Succesful use of gametes intrafallopian transfer does not reverse the decline in fertility
in women over 40 years of age. Obstet. Gynecol. 1991; 77: 37.
56. Persson I, Falkebom M, Lithell H and Adami HO. Hormone replacement
therapy and cardiovascular diseases -with special emphasis on combined therapy. En:
Samsioe G. "Cardiovascular disease and HRT. New perspectives". The Parthenon
Publishing Group, Camforth, New Jersey, 1991.
57. Rakoff AE. Female climateric: premenopause, menopause,
postmenopause. En: Gold JJ. "Gynecologic Endocrinology", "Harper & Row,
Publisher, Hagersdtown, Maryland, 1975.
58. Reginster JY, Denis D, Albert A, Deroisy R, Lecart MP, Fontaine MA
and Franchimont P: Intranasal calcitonin: a new horizon en prevention of early
postmenopausal bone loss. En: Christiansen C. "NewHorizons in Osteoporosis". The
Parthenon PublishingGroup Ltd., Camforth, 1988.
59. Riggs BL, and Spelberg TO Estrogen and bone. A report of a Mini
Symposium held at the Fourth International Symposium on Osteoporosis, Hong Kong, 27-31
March, 1993.
60. Samsoie G. Effects of hormone replacement therapy on lipid
metabolism and incidence of cardiovascular disease. En: Samsoie G. "Cardiovascular
disease and HRT. New Perspectives". The Parthenon Publishing Group, Camforth, New
Jersey, 1991.
61. Savvas M, Bishop J, Larent G, et al. Skin type III collagen content
in postmenopausal women with estradiol and testosterone implants. Br. J. Obstet. Gynaecol.
1993; 100: 154-156.
62. Salas RF. Factores relacionados con la edad de la menopausia,
Arequipa 198990. Tesis de Bachiller en Medicina. Universidad Nacional San Agustin de
Arequipa, 1990.
63. Schneider HPG. The climacteric syndrome. En: Greenblatt RB "A
Modern Approach to the Perimenopausal Years" Walter de Gruyter. Berlin- New York,
1986.
64. Siiteri PI: Extraglandular oestrogen formation and serum binding of
oestradiol: Relationship to cancer. J. Endocrinol 1981; 62: 1121.
65. Spicer D, Pike MC, and Henderson BE. The question of estrogen
replacement therapy in patients with a prior diagnosis of breast cancer. Oncology
Williston Park 4: 49-54, 59; discussion 1990; 59,62.
66. Stampfer MJ, Colditz GA, Willet WC, et al. Postmenopausal estrogen
therapy and cardiovascular disease: ten year follow-up from the Nurses Health Study. N.
Engl. J. Med. 1991; 325: 756-762.
67. Steinberg D, Parthasarathy S, Carew TE et A Beyond cholesterol.
Modifications of low density lipoproteins that increase its atherogenecity. N. Engl. J.
Med. 1989; 320: 915-920,
68. Stovall DW, Toma SK, Hammond MG, and Talbert LM. The effect of age
on female fecundity. Obstet. Gynecol. 1991; 77: 33.
69. Tikkanen MJ, Nikkilj EA, Kuusi T. Lipids, hortnonal status and the
cardiovascular system. En: Greenblatt RB "A Modem Approach to the Perimenopausal
Years"- Walter de Gruyter, Berlin- New York, 1986.
70. Utian WH and Serr D. The climacteric syndrome. en van Keep PA,
Greenblat RB and Albeaux Femet M "Consensus on Menopause Research". University
Park Press, Baltimore, 1976.
71. Utian WH Nonhormonal medication. En: Greenblatt RB. "A Modem
Approach to the Perimenopausal Years" Walterde Gruyter, Berlin- New York, 1986.
72. Vanhoutte PM. Endothelium derived vasoactive factors, platelets and
coronary disease. Schering Lecture. Berlin, 1992.
73. Van Keep PA y Lauritzen. Fronteras de la Investigación Hormonal.
Envejecimiento y estrógenos. S. Karger, Basilea, 1973.
74. van Keep PA y Lauritzen C. Los estrógenos en la Postmenopausia. S.
Karger, Basilea, 1975.
75. van Keep PA, Greenblatt RB, and Albeaux-Femet M. Consensus on
Menopause Research. University Park Press, Baltimore, 1976.
76. van Keep PA, and Haspels AA. Oestrogen Therapy During the
Climacteric and Afterwards. Excerpta Medica Amsterdam. 1977.
77. van Keep PA, Utian WH and Venneulen A. The Controversial
Climacteric. MTP Press Ltd., Lancaster- Boston- The Hague, 1982.
78. Versi E. The bladder in the menopausal women. En: Greenblatt RB
"A Modern Approach to the Menopausal Years". Walter de Gruyter, Berlin- New
York, 1986.
79. Vorherr H. Fibrocystic breast disease: pathophysiology,
pathomorphology, clinical picture, and management. Am. J. Obstet. Gynecol. 1986; 154: 161.
80. Whitehead MI and Schenkel L. Transdermal Hormone Replacement. Long-
term Effects. The Parhtenon Publishing Group, Varnforth/ New Jersey, 1990.
81. Wing RR, Matthews KA, Kuller LH, Meilahn En: Plantiga PL. Weight
gain at the time of menopause. Arch. Intern. Med. 1991; 151: 97-102.
82. Wolf PH, Madans JH, Finucane FF, Higgins M, and Kleinman JC.
Reduction of cardiovascular disease related mortality among postmenopausal women who use
hormones: evidence from a national cohort. Am. J. Obstet. Gynecol. 1991; 164: 489-94.
83. Young RL, Kumar NS and Godzieher JW. Management of menopause when
estrogen cannot be used. Drugs 1990; 40: 220-30.
